 |
LOAd703, a modified adenovirus 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand (TMZ-CD40L) and full length 4-1BBL |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-05-04 00:00:00 |
| Sponsor | Lokon Pharma AB;Dag Hammarskjoldsvag 40c, 751 83, Uppsala; |
